• Facebook Twitter
  • About
    • About POZEN
    • Letter from CEO John R. Plachetka
    • Executive Officer Bios
    • Board of Directors
    • Culture
    • Community Involvement
    • Careers
  • Products
    • Overview
    • Development Products
      • PA
    • Approved Products
      • Treximet®
      • VIMOVO™
    • Migraine Information
    • Arthritis Information
    • Cardiovascular Disease
    • Colorectal Cancer
    • Poster Presentations
    • Publications
    • FAQ
  • Investors
    • Overview
    • Fact Sheets
      • Corporate
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Investment Calculator
      • Historical Price Lookup
    • Quarterly Financials
    • Analyst Coverage & Estimates
    • Current & Archived Annual Reports
    • SEC Filings
    • IR Contact Information
    • E-mail Alerts
    • Information Request
    • FAQ
  • Media
    • Overview
    • Press Releases
      • 2012 Press Releases
      • 2011 Press Releases
      • 2010 Press Releases
      • 2009 Press Releases
      • 2008 Press Releases
      • 2007 Press Releases
      • 2006 Press Releases
      • 2005 Press Releases
      • 2004 Press Releases
      • Archives
    • Podcasts / Videos
    • Digital Advisory Board
    • Poster Presentations
  • Corporate Governance
    • Overview
    • Committee Composition
    • Charters
    • Code of Ethics
  • Business Development
  • Contact

About

  • About POZEN
  • Letter from CEO John R. Plachetka
  • Executive Officer Bios
  • Board of Directors
  • Culture
  • Community Involvement
  • Careers

Board of Directors

John R. Plachetka, Pharm.D.
President, Chief Executive Officer and Chairman of the Board of Directors

Neal F. Fowler

Arthur S. Kirsch

Angela M. Larson

Kenneth B. Lee, Jr.

James J. Mauzey

Martin Nicklasson, Ph.D.

Jacques F. Rejeange

Seth A. Rudnick, M.D.

 

  • All contents © 2005-2012 POZEN Inc. All Rights Reserved   »  Terms and Conditions  »  Site Map